What Insider Buying Is Saying About This Small ~$3 Biotech Concern

What Insider Buying Is Saying About This Small ~$3 Biotech Concern


Calithera Biosciences is a small biotechnology company that recently announced a collaboration with Bristol-Myers Squibb to test its enzyme inhibitor in combination with Opdivo. Recent trial results combined with recent insider buying suggest that this small ~$3 biotech stock is underappreciated with significant possible upside potential.



from Biotech News